KCE Trials focuses mainly on comparative clinical trials that can provide a large "return on investment". Comparative clinical trials compare the risks and benefits of a number of treatments, which are already in use, but which have never really been directly compared (eg. which of two treatments works best in real life?)
All types of health interventions, in all areas of health care, are eligible for the trials. KCE Trials is therefore not only limited to medicines or medical devices; a wide range of other interventions, such as psychotherapy, diets, lifestyle interventions, diagnostic tests, surgery or types of care, can also be addressed. An absolute condition is that the result of the trial has an immediate impact on the care of patients or on the efficient use of the available healthcare resources.
KCE Trials does not fund clinical research in the early stages of drug development. For this, it is best to contact other institutions, such as the Fonds voor Wetenschappelijk Onderzoek, the Fonds de la Recherche Scientifique and Innoviris (for more information, see https://kce.fgov.be/en/public-funding-sources-for-trials). Implementation research does not fall within the scope of KCE Trials either.